• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Rev's Forum: Pension Fund Rebalancing Acts Could Impact 2016's Finish

Will pension funds sell stocks after their run higher in order to maintain the same allocation levels to bonds and equities?
By JAMES "REV SHARK" DEPORRE
Dec 28, 2016 | 08:00 AM EST
Stocks quotes in this article: NAK, CNAT, CETX, NVDA

"People do not like to think. If one thinks, one must reach conclusions. Conclusions are not always pleasant."

--Helen Keller

Trading for the year is quickly coming to an end. With only three full days of action left the big question is whether some last-minute games will trip up traders who are anticipating that a Santa Claus rally will continue without interruption.

If we look back at the action the last two years we see that the market stumbled in the last two trading days before the calendar flipped over. This sort of action is caused by any number of things, such as tax issues, portfolio positioning and a desire to start the New Year with a clean slate.

One issue that may arise in the waning days of 2016 is asset allocation by pension funds. The S&P 500 is up sharply since the election and if funds want to maintain the same level of allocations to bonds and equities they will need to sell nearly $40 billion of stock. There is no guarantee that funds will keep the allocation between bonds and stocks the same, but there is going to be some pressures in this regard as things wind down.

While allocations and tax issues will be major factors in the next couple days, the good news is that traders are enjoying some old-fashioned holiday trading. We had some great examples of big movement in small-cap names yesterday. Names such as Northern Dynasty Minerals (NAK) , Conatus Pharmaceuticals (CNAT) and Cemtrex (CETX) offered great opportunities for aggressive traders. NVIDIA (NVDA) showed how end-of-the-year window dressing can benefit big-caps as well.

The Dow Jones Industrial Average still is struggling to generate enough momentum to take out the 20,000 level. I was a bit surprised it didn't accomplish the deed yesterday, but after an early push the momentum rotated into the small-cap speculative names. Strength in oil helped to keep things in the green, but softness in biotechnology helped to produce a close at the lows of the day. Despite the softness in the DJIA, breadth was very strong as small-cap names outperformed.

The early action this morning does not appear strong enough to push the DJIA to the 20,000 level. There is little news flow and volume is very slow, but all it will take is one decent buy program to accomplish the deed. I suspect that the 20,000 level will not hold for long, but at least the annoying news coverage will slow.

My game plan is to be ready for some allocations into the end of the year to cause volatility.I'm focused on the small-cap trades that are working and likely will have an extremely high level of cash when we close trading for the year. If I can knock out a few more gains during the Santa Claus rally, I'll be happy to start 2017 with a clean slate and a fresh perspective.

It is holiday trading right now, but that doesn't mean that we won't see some downside action in the next couple days.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long NAK and CETX.

TAGS: Investing | U.S. Equity | Healthcare | Technology | Basic Materials | Markets | Stocks

More from Healthcare

This Won't Hurt a Bit: Moderna Could Rally 25% From Here

Bruce Kamich
Jul 6, 2022 2:59 PM EDT

The stock is ready to make a recovery rally.

Bearish Bets: 3 Stocks You Should Consider Shorting This Week

Bob Lang
Jul 3, 2022 10:30 AM EDT

These recently downgraded names are displaying both quantitative and technical deterioration.

Nuvalent Has Begun the Bottoming Process

Bruce Kamich
Jul 1, 2022 10:52 AM EDT

Let's check the charts and indicators.

CRISPR Therapeutics Has Turned the Corner

Bruce Kamich
Jul 1, 2022 8:43 AM EDT

Here's our current price target.

Johnson & Johnson Appears to Be Running Out of Steam

Bruce Kamich
Jun 22, 2022 8:25 AM EDT

The shares of the healthcare giant have been in a long-term uptrend but could break that trend in the weeks ahead.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:01 PM EDT PAUL PRICE

    A Recent Director Buy in Children's Place (PLCE)

    Four of the most recent insider trades in Children...
  • 07:34 AM EDT PAUL PRICE

    A $525,000 Vote of Confidence on Macerich (MAC)

  • 09:49 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Stop Wishing, Hoping, and Praying and Take Control...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login